RESEARCHER PROFILE
Jacques P. Tremblay
J
Université Laval
Jacques P. Tremblay works in Muscle Physiology and Disorders, Neurogenetic and Muscular Disorders Research, Virus-based gene therapy research, Pluripotent Stem Cells Research, CRISPR and Genetic Engineering. Recorded institutional associations include Centre hospitalier universitaire de Québec, Université Laval, Centre de recherche du CHU de Québec-Université Laval.
382Publications
12,858Citations
58H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Current Clinical Applications of In Vivo Gene Therapy with AAVs
2020 · 738 citationsStem and Progenitor Cells in Skeletal Muscle Development, Maintenance, and Therapy
2007 · 576 citationsResults of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular Dystrophy
1993 · 345 citationsIntraarterial Injection of Muscle-Derived Cd34+Sca-1+ Stem Cells Restores Dystrophin in mdx Mice
2001 · 262 citationsHuman myoblast transplantation: Preliminary results of 4 cases
1992 · 253 citationsDystrophin Expression in Muscles of Duchenne Muscular Dystrophy Patients After High-Density Injections of Normal Myogenic Cells
2006 · 238 citationsDystrophin Expression in Myofibers of Duchenne Muscular Dystrophy Patients Following Intramuscular Injections of Normal Myogenic Cells
2004 · 197 citationsFirst test of a “high-density injection” protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up
2006 · 196 citationsVery efficient myoblast allotransplantation in mice under FK506 immunosuppression
1994 · 196 citationsCurrent Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD
2011 · 193 citationsReading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients
2013 · 181 citationsMyoblasts Derived From Normal hESCs and Dystrophic hiPSCs Efficiently Fuse With Existing Muscle Fibers Following Transplantation
2012 · 173 citationsIn Vivo Migration of Transplanted Myoblasts Requires Matrix Metalloproteinase Activity
2000 · 161 citationsFK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene Transfer
1995 · 160 citationsHigh efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.
1994 · 160 citationsMuscle fibers of mdx mice are more vulnerable to exercise than those of normal mice
1997 · 152 citationsIntracellular Delivery of a Tat-eGFP Fusion Protein into Muscle Cells
2001 · 145 citationsPrevention by anti-LFA-1 of acute myoblast death following transplantation
1997 · 135 citationsEvidence ofmdx mouse skeletal muscle fragility in vivo by eccentric running exercise
1998 · 122 citationsEndosome disruption enhances the functional nuclear delivery of Tat-fusion proteins
2004 · 116 citationsEfficacy of Myoblast Transplantation in Nonhuman Primates Following Simple Intramuscular Cell Injections: Toward Defining Strategies Applicable to Humans
2002 · 107 citationsSuccessful Myoblast Transplantation in Primates Depends on Appropriate Cell Delivery and Induction of Regeneration in the Host Muscle
1999 · 105 citationsAutologous Transplantation of Muscle Precursor Cells Modified with a Lentivirus for Muscular Dystrophy: Human Cells and Primate Models
2007 · 100 citationsElectrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies
2001 · 100 citationsHuman myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection
1994 · 99 citations
